- Home
- DCGO vs THTX Comparison
DCGO vs THTX Comparison
Compare DCGO & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- THTX
- Stock Information
- Founded
- DCGO 2015
- THTX 1993
- Country
- DCGO United States
- THTX Canada
- Employees
- DCGO N/A
- THTX N/A
- Industry
- DCGO Managed Health Care
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- DCGO Health Care
- THTX Health Care
- Exchange
- DCGO Nasdaq
- THTX Nasdaq
- Market Cap
- DCGO 139.7M
- THTX 144.8M
- IPO Year
- DCGO N/A
- THTX N/A
- Fundamental
- Price
- DCGO $1.62
- THTX $3.24
- Analyst Decision
- DCGO Strong Buy
- THTX Hold
- Analyst Count
- DCGO 4
- THTX 1
- Target Price
- DCGO $3.74
- THTX N/A
- AVG Volume (30 Days)
- DCGO 549.4K
- THTX 249.2K
- Earning Date
- DCGO 08-07-2025
- THTX 10-09-2025
- Dividend Yield
- DCGO N/A
- THTX N/A
- EPS Growth
- DCGO N/A
- THTX N/A
- EPS
- DCGO N/A
- THTX N/A
- Revenue
- DCGO $435,968,564.00
- THTX $84,378,000.00
- Revenue This Year
- DCGO N/A
- THTX N/A
- Revenue Next Year
- DCGO $4.08
- THTX $13.76
- P/E Ratio
- DCGO N/A
- THTX N/A
- Revenue Growth
- DCGO N/A
- THTX 2.19
- 52 Week Low
- DCGO $1.23
- THTX $1.12
- 52 Week High
- DCGO $5.68
- THTX $3.25
- Technical
- Relative Strength Index (RSI)
- DCGO 57.01
- THTX 74.26
- Support Level
- DCGO $1.37
- THTX $3.18
- Resistance Level
- DCGO $1.76
- THTX $3.22
- Average True Range (ATR)
- DCGO 0.10
- THTX 0.02
- MACD
- DCGO 0.03
- THTX -0.01
- Stochastic Oscillator
- DCGO 66.32
- THTX 90.00
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.